Skip to main content
Andrew Folpe, MD, Pathology, Rochester, MN, Mayo Clinic Hospital - Rochester

AndrewLFolpeMD

Pathology Rochester, MN

Cytopathology, Anatomic Pathology, Clinical Pathology

Professor, Laboratory Medicine & Pathology, Mayo Medical School

Dr. Folpe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Folpe's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonResidency, Pathology-Anatomic and Clinical, 1994 - 1998
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1994

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2006 - 2024
  • GA State Medical License
    GA State Medical License 1998 - 2007
  • WA State Medical License
    WA State Medical License 1997 - 1998
  • American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Journal Articles

  • Original Contribution Immunohistochemistry for TFE3 Lacks Specificity and Sensitivity in the Diagnosis of TFE3-Rearranged Neoplasms: A Comparative, Two-Laboratory Study☆  
    Andrew L Folpe, Rosalind F Sharain, Patricia T Greipp, ScienceDirect
  • Histiocyte-Rich Rhabdomyoblastic Tumor: Rhabdomyosarcoma, Rhabdomyoma, or Rhabdomyoblastic Tumor of Uncertain Malignant Potential? A Histologically Distinctive Rhabdom...  
    Sharon W Weiss, Andrew L Folpe, Karen J Fritchie, Armita Bahrami, Nature
  • Malignant Tenosynovial Giant Cell Tumor: The True “Synovial Sarcoma?” A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting...  
    William Albert Ahrens, Bonnie Balzer, Karen Fritchie, Andrew L Folpe, Nature
  • Join now to see all

Lectures

  • Aberrant Receptor Tyrosine Kinase Signaling in Lipofibromatosis: A Clinicopathological and Molecular Genetic Study of 20 Cases 
    Medical College of Wisconsin, Milwaukee, Wisconsin - 9/20/2013

Press Mentions

  • Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy with a Simultaneous Integrated Boost
    Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy with a Simultaneous Integrated BoostSeptember 22nd, 2020
  • What’s New in Fibroblastic Tumors?
    What’s New in Fibroblastic Tumors?December 11th, 2019

Hospital Affiliations